NCT03845127: A trial that was reported late by BioVentrix
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT03845127 |
|---|---|
| Title | Randomized Evaluation and Verification of Ventricular Enhancement: The REVIVE-HF Study |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 1, 2020 |
| Completion date | Dec. 31, 2024 |
| Required reporting date | Dec. 31, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | April 11, 2025 |
| Days late | None |